The global GLP-1 Drug market size was valued at USD 21020 million in 2022 and is forecast to a readjusted size of USD 98000 million by 2029 with a CAGR of 24.6% during review period.
Report includes an overview of the development of the GLP-1 Drug industry chain, the market status of Obesity (Short-acting GLP-1 Drug, Long-acting GLP-1 Drug), Type 2 Diabetes (T2DM) (Short-acting GLP-1 Drug, Long-acting GLP-1 Drug), and key enterprises in developed and developing market, and analyzed the cutting-edge technology, patent, hot applications and market trends of GLP-1 Drug.
Regionally, the report analyzes the GLP-1 Drug markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global GLP-1 Drug market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the GLP-1 Drug market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the GLP-1 Drug industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Short-acting GLP-1 Drug, Long-acting GLP-1 Drug).
Industry Analysis: Report analyze the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the GLP-1 Drug market.
Regional Analysis: The report involves examining the GLP-1 Drug market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behavior to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the GLP-1 Drug market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to GLP-1 Drug:
Company Analysis: Report covers individual GLP-1 Drug manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards GLP-1 Drug This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Obesity, Type 2 Diabetes (T2DM)).
Technology Analysis: Report covers specific technologies relevant to GLP-1 Drug. It assesses the current state, advancements, and potential future developments in GLP-1 Drug areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the GLP-1 Drug market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Eli Lilly
AstraZeneca
Sanofi
Pfizer Inc
Novo Nordisk
Boehringer Ingelheim
GlaxoSmithKline (GSK)
East China Pharmaceutical Co., Ltd.
Gan & Lee Pharmaceuticals
Tonghua Dongbao
Shanghai Renhui Biopharmaceutical Co., Ltd.
Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
Short-acting GLP-1 Drug
Long-acting GLP-1 Drug
Obesity
Type 2 Diabetes (T2DM)
Cardiovascular and Cerebrovascular Diseases (CVD)
Non-alcoholic Steatohepatitis (NASH)
Alzheimer's Disease (AD)
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe GLP-1 Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of GLP-1 Drug, with price, sales, revenue and global market share of GLP-1 Drug from 2018 to 2023.
Chapter 3, the GLP-1 Drug competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the GLP-1 Drug breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and GLP-1 Drug market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of GLP-1 Drug.
Chapter 14 and 15, to describe GLP-1 Drug sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of GLP-1 Drug
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global GLP-1 Drug Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Short-acting GLP-1 Drug
1.3.3 Long-acting GLP-1 Drug
1.4 Market Analysis by Application
1.4.1 Overview: Global GLP-1 Drug Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Obesity
1.4.3 Type 2 Diabetes (T2DM)
1.4.4 Cardiovascular and Cerebrovascular Diseases (CVD)
1.4.5 Non-alcoholic Steatohepatitis (NASH)
1.4.6 Alzheimer's Disease (AD)
1.5 Global GLP-1 Drug Market Size & Forecast
1.5.1 Global GLP-1 Drug Consumption Value (2018 & 2022 & 2029)
1.5.2 Global GLP-1 Drug Sales Quantity (2018-2029)
1.5.3 Global GLP-1 Drug Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Eli Lilly
2.1.1 Eli Lilly Details
2.1.2 Eli Lilly Major Business
2.1.3 Eli Lilly GLP-1 Drug Product and Services
2.1.4 Eli Lilly GLP-1 Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Eli Lilly Recent Developments/Updates
2.2 AstraZeneca
2.2.1 AstraZeneca Details
2.2.2 AstraZeneca Major Business
2.2.3 AstraZeneca GLP-1 Drug Product and Services
2.2.4 AstraZeneca GLP-1 Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 AstraZeneca Recent Developments/Updates
2.3 Sanofi
2.3.1 Sanofi Details
2.3.2 Sanofi Major Business
2.3.3 Sanofi GLP-1 Drug Product and Services
2.3.4 Sanofi GLP-1 Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Sanofi Recent Developments/Updates
2.4 Pfizer Inc
2.4.1 Pfizer Inc Details
2.4.2 Pfizer Inc Major Business
2.4.3 Pfizer Inc GLP-1 Drug Product and Services
2.4.4 Pfizer Inc GLP-1 Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Pfizer Inc Recent Developments/Updates
2.5 Novo Nordisk
2.5.1 Novo Nordisk Details
2.5.2 Novo Nordisk Major Business
2.5.3 Novo Nordisk GLP-1 Drug Product and Services
2.5.4 Novo Nordisk GLP-1 Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Novo Nordisk Recent Developments/Updates
2.6 Boehringer Ingelheim
2.6.1 Boehringer Ingelheim Details
2.6.2 Boehringer Ingelheim Major Business
2.6.3 Boehringer Ingelheim GLP-1 Drug Product and Services
2.6.4 Boehringer Ingelheim GLP-1 Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Boehringer Ingelheim Recent Developments/Updates
2.7 GlaxoSmithKline (GSK)
2.7.1 GlaxoSmithKline (GSK) Details
2.7.2 GlaxoSmithKline (GSK) Major Business
2.7.3 GlaxoSmithKline (GSK) GLP-1 Drug Product and Services
2.7.4 GlaxoSmithKline (GSK) GLP-1 Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 GlaxoSmithKline (GSK) Recent Developments/Updates
2.8 East China Pharmaceutical Co., Ltd.
2.8.1 East China Pharmaceutical Co., Ltd. Details
2.8.2 East China Pharmaceutical Co., Ltd. Major Business
2.8.3 East China Pharmaceutical Co., Ltd. GLP-1 Drug Product and Services
2.8.4 East China Pharmaceutical Co., Ltd. GLP-1 Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 East China Pharmaceutical Co., Ltd. Recent Developments/Updates
2.9 Gan & Lee Pharmaceuticals
2.9.1 Gan & Lee Pharmaceuticals Details
2.9.2 Gan & Lee Pharmaceuticals Major Business
2.9.3 Gan & Lee Pharmaceuticals GLP-1 Drug Product and Services
2.9.4 Gan & Lee Pharmaceuticals GLP-1 Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Gan & Lee Pharmaceuticals Recent Developments/Updates
2.10 Tonghua Dongbao
2.10.1 Tonghua Dongbao Details
2.10.2 Tonghua Dongbao Major Business
2.10.3 Tonghua Dongbao GLP-1 Drug Product and Services
2.10.4 Tonghua Dongbao GLP-1 Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Tonghua Dongbao Recent Developments/Updates
2.11 Shanghai Renhui Biopharmaceutical Co., Ltd.
2.11.1 Shanghai Renhui Biopharmaceutical Co., Ltd. Details
2.11.2 Shanghai Renhui Biopharmaceutical Co., Ltd. Major Business
2.11.3 Shanghai Renhui Biopharmaceutical Co., Ltd. GLP-1 Drug Product and Services
2.11.4 Shanghai Renhui Biopharmaceutical Co., Ltd. GLP-1 Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Shanghai Renhui Biopharmaceutical Co., Ltd. Recent Developments/Updates
2.12 Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
2.12.1 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Details
2.12.2 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Major Business
2.12.3 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. GLP-1 Drug Product and Services
2.12.4 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. GLP-1 Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Recent Developments/Updates
3 Competitive Environment: GLP-1 Drug by Manufacturer
3.1 Global GLP-1 Drug Sales Quantity by Manufacturer (2018-2023)
3.2 Global GLP-1 Drug Revenue by Manufacturer (2018-2023)
3.3 Global GLP-1 Drug Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of GLP-1 Drug by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 GLP-1 Drug Manufacturer Market Share in 2022
3.4.2 Top 6 GLP-1 Drug Manufacturer Market Share in 2022
3.5 GLP-1 Drug Market: Overall Company Footprint Analysis
3.5.1 GLP-1 Drug Market: Region Footprint
3.5.2 GLP-1 Drug Market: Company Product Type Footprint
3.5.3 GLP-1 Drug Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global GLP-1 Drug Market Size by Region
4.1.1 Global GLP-1 Drug Sales Quantity by Region (2018-2029)
4.1.2 Global GLP-1 Drug Consumption Value by Region (2018-2029)
4.1.3 Global GLP-1 Drug Average Price by Region (2018-2029)
4.2 North America GLP-1 Drug Consumption Value (2018-2029)
4.3 Europe GLP-1 Drug Consumption Value (2018-2029)
4.4 Asia-Pacific GLP-1 Drug Consumption Value (2018-2029)
4.5 South America GLP-1 Drug Consumption Value (2018-2029)
4.6 Middle East and Africa GLP-1 Drug Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global GLP-1 Drug Sales Quantity by Type (2018-2029)
5.2 Global GLP-1 Drug Consumption Value by Type (2018-2029)
5.3 Global GLP-1 Drug Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global GLP-1 Drug Sales Quantity by Application (2018-2029)
6.2 Global GLP-1 Drug Consumption Value by Application (2018-2029)
6.3 Global GLP-1 Drug Average Price by Application (2018-2029)
7 North America
7.1 North America GLP-1 Drug Sales Quantity by Type (2018-2029)
7.2 North America GLP-1 Drug Sales Quantity by Application (2018-2029)
7.3 North America GLP-1 Drug Market Size by Country
7.3.1 North America GLP-1 Drug Sales Quantity by Country (2018-2029)
7.3.2 North America GLP-1 Drug Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe GLP-1 Drug Sales Quantity by Type (2018-2029)
8.2 Europe GLP-1 Drug Sales Quantity by Application (2018-2029)
8.3 Europe GLP-1 Drug Market Size by Country
8.3.1 Europe GLP-1 Drug Sales Quantity by Country (2018-2029)
8.3.2 Europe GLP-1 Drug Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific GLP-1 Drug Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific GLP-1 Drug Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific GLP-1 Drug Market Size by Region
9.3.1 Asia-Pacific GLP-1 Drug Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific GLP-1 Drug Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America GLP-1 Drug Sales Quantity by Type (2018-2029)
10.2 South America GLP-1 Drug Sales Quantity by Application (2018-2029)
10.3 South America GLP-1 Drug Market Size by Country
10.3.1 South America GLP-1 Drug Sales Quantity by Country (2018-2029)
10.3.2 South America GLP-1 Drug Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa GLP-1 Drug Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa GLP-1 Drug Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa GLP-1 Drug Market Size by Country
11.3.1 Middle East & Africa GLP-1 Drug Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa GLP-1 Drug Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 GLP-1 Drug Market Drivers
12.2 GLP-1 Drug Market Restraints
12.3 GLP-1 Drug Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
13.1 Raw Material of GLP-1 Drug and Key Manufacturers
13.2 Manufacturing Costs Percentage of GLP-1 Drug
13.3 GLP-1 Drug Production Process
13.4 GLP-1 Drug Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 GLP-1 Drug Typical Distributors
14.3 GLP-1 Drug Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
List of Tables
Table 1. Global GLP-1 Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global GLP-1 Drug Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 4. Eli Lilly Major Business
Table 5. Eli Lilly GLP-1 Drug Product and Services
Table 6. Eli Lilly GLP-1 Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Eli Lilly Recent Developments/Updates
Table 8. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 9. AstraZeneca Major Business
Table 10. AstraZeneca GLP-1 Drug Product and Services
Table 11. AstraZeneca GLP-1 Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. AstraZeneca Recent Developments/Updates
Table 13. Sanofi Basic Information, Manufacturing Base and Competitors
Table 14. Sanofi Major Business
Table 15. Sanofi GLP-1 Drug Product and Services
Table 16. Sanofi GLP-1 Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Sanofi Recent Developments/Updates
Table 18. Pfizer Inc Basic Information, Manufacturing Base and Competitors
Table 19. Pfizer Inc Major Business
Table 20. Pfizer Inc GLP-1 Drug Product and Services
Table 21. Pfizer Inc GLP-1 Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Pfizer Inc Recent Developments/Updates
Table 23. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 24. Novo Nordisk Major Business
Table 25. Novo Nordisk GLP-1 Drug Product and Services
Table 26. Novo Nordisk GLP-1 Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Novo Nordisk Recent Developments/Updates
Table 28. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 29. Boehringer Ingelheim Major Business
Table 30. Boehringer Ingelheim GLP-1 Drug Product and Services
Table 31. Boehringer Ingelheim GLP-1 Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Boehringer Ingelheim Recent Developments/Updates
Table 33. GlaxoSmithKline (GSK) Basic Information, Manufacturing Base and Competitors
Table 34. GlaxoSmithKline (GSK) Major Business
Table 35. GlaxoSmithKline (GSK) GLP-1 Drug Product and Services
Table 36. GlaxoSmithKline (GSK) GLP-1 Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. GlaxoSmithKline (GSK) Recent Developments/Updates
Table 38. East China Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 39. East China Pharmaceutical Co., Ltd. Major Business
Table 40. East China Pharmaceutical Co., Ltd. GLP-1 Drug Product and Services
Table 41. East China Pharmaceutical Co., Ltd. GLP-1 Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. East China Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 43. Gan & Lee Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 44. Gan & Lee Pharmaceuticals Major Business
Table 45. Gan & Lee Pharmaceuticals GLP-1 Drug Product and Services
Table 46. Gan & Lee Pharmaceuticals GLP-1 Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Gan & Lee Pharmaceuticals Recent Developments/Updates
Table 48. Tonghua Dongbao Basic Information, Manufacturing Base and Competitors
Table 49. Tonghua Dongbao Major Business
Table 50. Tonghua Dongbao GLP-1 Drug Product and Services
Table 51. Tonghua Dongbao GLP-1 Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Tonghua Dongbao Recent Developments/Updates
Table 53. Shanghai Renhui Biopharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 54. Shanghai Renhui Biopharmaceutical Co., Ltd. Major Business
Table 55. Shanghai Renhui Biopharmaceutical Co., Ltd. GLP-1 Drug Product and Services
Table 56. Shanghai Renhui Biopharmaceutical Co., Ltd. GLP-1 Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Shanghai Renhui Biopharmaceutical Co., Ltd. Recent Developments/Updates
Table 58. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 59. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Major Business
Table 60. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. GLP-1 Drug Product and Services
Table 61. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. GLP-1 Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Recent Developments/Updates
Table 63. Global GLP-1 Drug Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 64. Global GLP-1 Drug Revenue by Manufacturer (2018-2023) & (USD Million)
Table 65. Global GLP-1 Drug Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 66. Market Position of Manufacturers in GLP-1 Drug, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 67. Head Office and GLP-1 Drug Production Site of Key Manufacturer
Table 68. GLP-1 Drug Market: Company Product Type Footprint
Table 69. GLP-1 Drug Market: Company Product Application Footprint
Table 70. GLP-1 Drug New Market Entrants and Barriers to Market Entry
Table 71. GLP-1 Drug Mergers, Acquisition, Agreements, and Collaborations
Table 72. Global GLP-1 Drug Sales Quantity by Region (2018-2023) & (K Units)
Table 73. Global GLP-1 Drug Sales Quantity by Region (2024-2029) & (K Units)
Table 74. Global GLP-1 Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 75. Global GLP-1 Drug Consumption Value by Region (2024-2029) & (USD Million)
Table 76. Global GLP-1 Drug Average Price by Region (2018-2023) & (US$/Unit)
Table 77. Global GLP-1 Drug Average Price by Region (2024-2029) & (US$/Unit)
Table 78. Global GLP-1 Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 79. Global GLP-1 Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 80. Global GLP-1 Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 81. Global GLP-1 Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 82. Global GLP-1 Drug Average Price by Type (2018-2023) & (US$/Unit)
Table 83. Global GLP-1 Drug Average Price by Type (2024-2029) & (US$/Unit)
Table 84. Global GLP-1 Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 85. Global GLP-1 Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 86. Global GLP-1 Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 87. Global GLP-1 Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 88. Global GLP-1 Drug Average Price by Application (2018-2023) & (US$/Unit)
Table 89. Global GLP-1 Drug Average Price by Application (2024-2029) & (US$/Unit)
Table 90. North America GLP-1 Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 91. North America GLP-1 Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 92. North America GLP-1 Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 93. North America GLP-1 Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 94. North America GLP-1 Drug Sales Quantity by Country (2018-2023) & (K Units)
Table 95. North America GLP-1 Drug Sales Quantity by Country (2024-2029) & (K Units)
Table 96. North America GLP-1 Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 97. North America GLP-1 Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 98. Europe GLP-1 Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 99. Europe GLP-1 Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 100. Europe GLP-1 Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 101. Europe GLP-1 Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 102. Europe GLP-1 Drug Sales Quantity by Country (2018-2023) & (K Units)
Table 103. Europe GLP-1 Drug Sales Quantity by Country (2024-2029) & (K Units)
Table 104. Europe GLP-1 Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 105. Europe GLP-1 Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 106. Asia-Pacific GLP-1 Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 107. Asia-Pacific GLP-1 Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 108. Asia-Pacific GLP-1 Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 109. Asia-Pacific GLP-1 Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 110. Asia-Pacific GLP-1 Drug Sales Quantity by Region (2018-2023) & (K Units)
Table 111. Asia-Pacific GLP-1 Drug Sales Quantity by Region (2024-2029) & (K Units)
Table 112. Asia-Pacific GLP-1 Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 113. Asia-Pacific GLP-1 Drug Consumption Value by Region (2024-2029) & (USD Million)
Table 114. South America GLP-1 Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 115. South America GLP-1 Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 116. South America GLP-1 Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 117. South America GLP-1 Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 118. South America GLP-1 Drug Sales Quantity by Country (2018-2023) & (K Units)
Table 119. South America GLP-1 Drug Sales Quantity by Country (2024-2029) & (K Units)
Table 120. South America GLP-1 Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 121. South America GLP-1 Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 122. Middle East & Africa GLP-1 Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 123. Middle East & Africa GLP-1 Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 124. Middle East & Africa GLP-1 Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 125. Middle East & Africa GLP-1 Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 126. Middle East & Africa GLP-1 Drug Sales Quantity by Region (2018-2023) & (K Units)
Table 127. Middle East & Africa GLP-1 Drug Sales Quantity by Region (2024-2029) & (K Units)
Table 128. Middle East & Africa GLP-1 Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 129. Middle East & Africa GLP-1 Drug Consumption Value by Region (2024-2029) & (USD Million)
Table 130. GLP-1 Drug Raw Material
Table 131. Key Manufacturers of GLP-1 Drug Raw Materials
Table 132. GLP-1 Drug Typical Distributors
Table 133. GLP-1 Drug Typical Customers
List of Figures
Figure 1. GLP-1 Drug Picture
Figure 2. Global GLP-1 Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global GLP-1 Drug Consumption Value Market Share by Type in 2022
Figure 4. Short-acting GLP-1 Drug Examples
Figure 5. Long-acting GLP-1 Drug Examples
Figure 6. Global GLP-1 Drug Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global GLP-1 Drug Consumption Value Market Share by Application in 2022
Figure 8. Obesity Examples
Figure 9. Type 2 Diabetes (T2DM) Examples
Figure 10. Cardiovascular and Cerebrovascular Diseases (CVD) Examples
Figure 11. Non-alcoholic Steatohepatitis (NASH) Examples
Figure 12. Alzheimer's Disease (AD) Examples
Figure 13. Global GLP-1 Drug Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 14. Global GLP-1 Drug Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 15. Global GLP-1 Drug Sales Quantity (2018-2029) & (K Units)
Figure 16. Global GLP-1 Drug Average Price (2018-2029) & (US$/Unit)
Figure 17. Global GLP-1 Drug Sales Quantity Market Share by Manufacturer in 2022
Figure 18. Global GLP-1 Drug Consumption Value Market Share by Manufacturer in 2022
Figure 19. Producer Shipments of GLP-1 Drug by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 20. Top 3 GLP-1 Drug Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Top 6 GLP-1 Drug Manufacturer (Consumption Value) Market Share in 2022
Figure 22. Global GLP-1 Drug Sales Quantity Market Share by Region (2018-2029)
Figure 23. Global GLP-1 Drug Consumption Value Market Share by Region (2018-2029)
Figure 24. North America GLP-1 Drug Consumption Value (2018-2029) & (USD Million)
Figure 25. Europe GLP-1 Drug Consumption Value (2018-2029) & (USD Million)
Figure 26. Asia-Pacific GLP-1 Drug Consumption Value (2018-2029) & (USD Million)
Figure 27. South America GLP-1 Drug Consumption Value (2018-2029) & (USD Million)
Figure 28. Middle East & Africa GLP-1 Drug Consumption Value (2018-2029) & (USD Million)
Figure 29. Global GLP-1 Drug Sales Quantity Market Share by Type (2018-2029)
Figure 30. Global GLP-1 Drug Consumption Value Market Share by Type (2018-2029)
Figure 31. Global GLP-1 Drug Average Price by Type (2018-2029) & (US$/Unit)
Figure 32. Global GLP-1 Drug Sales Quantity Market Share by Application (2018-2029)
Figure 33. Global GLP-1 Drug Consumption Value Market Share by Application (2018-2029)
Figure 34. Global GLP-1 Drug Average Price by Application (2018-2029) & (US$/Unit)
Figure 35. North America GLP-1 Drug Sales Quantity Market Share by Type (2018-2029)
Figure 36. North America GLP-1 Drug Sales Quantity Market Share by Application (2018-2029)
Figure 37. North America GLP-1 Drug Sales Quantity Market Share by Country (2018-2029)
Figure 38. North America GLP-1 Drug Consumption Value Market Share by Country (2018-2029)
Figure 39. United States GLP-1 Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Canada GLP-1 Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Mexico GLP-1 Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Europe GLP-1 Drug Sales Quantity Market Share by Type (2018-2029)
Figure 43. Europe GLP-1 Drug Sales Quantity Market Share by Application (2018-2029)
Figure 44. Europe GLP-1 Drug Sales Quantity Market Share by Country (2018-2029)
Figure 45. Europe GLP-1 Drug Consumption Value Market Share by Country (2018-2029)
Figure 46. Germany GLP-1 Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. France GLP-1 Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. United Kingdom GLP-1 Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Russia GLP-1 Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Italy GLP-1 Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Asia-Pacific GLP-1 Drug Sales Quantity Market Share by Type (2018-2029)
Figure 52. Asia-Pacific GLP-1 Drug Sales Quantity Market Share by Application (2018-2029)
Figure 53. Asia-Pacific GLP-1 Drug Sales Quantity Market Share by Region (2018-2029)
Figure 54. Asia-Pacific GLP-1 Drug Consumption Value Market Share by Region (2018-2029)
Figure 55. China GLP-1 Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Japan GLP-1 Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Korea GLP-1 Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. India GLP-1 Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Southeast Asia GLP-1 Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. Australia GLP-1 Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. South America GLP-1 Drug Sales Quantity Market Share by Type (2018-2029)
Figure 62. South America GLP-1 Drug Sales Quantity Market Share by Application (2018-2029)
Figure 63. South America GLP-1 Drug Sales Quantity Market Share by Country (2018-2029)
Figure 64. South America GLP-1 Drug Consumption Value Market Share by Country (2018-2029)
Figure 65. Brazil GLP-1 Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Argentina GLP-1 Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 67. Middle East & Africa GLP-1 Drug Sales Quantity Market Share by Type (2018-2029)
Figure 68. Middle East & Africa GLP-1 Drug Sales Quantity Market Share by Application (2018-2029)
Figure 69. Middle East & Africa GLP-1 Drug Sales Quantity Market Share by Region (2018-2029)
Figure 70. Middle East & Africa GLP-1 Drug Consumption Value Market Share by Region (2018-2029)
Figure 71. Turkey GLP-1 Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Egypt GLP-1 Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Saudi Arabia GLP-1 Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. South Africa GLP-1 Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. GLP-1 Drug Market Drivers
Figure 76. GLP-1 Drug Market Restraints
Figure 77. GLP-1 Drug Market Trends
Figure 78. Porters Five Forces Analysis
Figure 79. Manufacturing Cost Structure Analysis of GLP-1 Drug in 2022
Figure 80. Manufacturing Process Analysis of GLP-1 Drug
Figure 81. GLP-1 Drug Industrial Chain
Figure 82. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 83. Direct Channel Pros & Cons
Figure 84. Indirect Channel Pros & Cons
Figure 85. Methodology
Figure 86. Research Process and Data Source
